The review by the Directorate General for Health Surveillance suggests that in the scenario of the omicron variant of COVID-19from an performance of 30.4% with the to start with dose, it goes to 72.4% with the application of reinforcements.
The methodology used for this examine responds to the proposal inside the Community for the Analysis of the Performance of the Vaccine in Latin The us and the Caribbean – impact and Covid-19, of the Pan American Well being Firm (PAHO), reviews the Wellness Portfolio Paraguayan.
The final results offered in this report appear from knowledge offered by this network for the interval in between May 2021 and April 2022.
A overall of 4,512 clients ended up evaluated for this goal, largely from the metropolitan location of Asunción and two from Alto Paraná.
According to the research, for the predominant circulation time period of the Gamma variant (Could 1 to August 7, 2021), all vaccines had been 42% efficient when vaccination was partial. 56.3% efficacy with all vaccines, in total vaccination (two-dose key card).
Associated: Health urges you to comprehensive your vaccination timetable to secure you
For the predominant circulation period of time of the Delta variant (from 22 August to 18 December 2021) it was observed that the success in cutting down hospitalizations was in between 69.4% and 80.3%, depending on the completeness of the principal plan, Well being Reports.
For the predominant circulation period of time of the Omicron variant (January 2 to April 2, 2022) an efficacy of 30.4% was observed total, devoid of a booster dose, an efficacy of 72.4% with all vaccines furthermore the reinforcement of the dose.
All through this interval it was observed that if the vaccine is the latest (significantly less than 90 times in between infection and the past dose), the performance in cutting down hospitalization reaches 78.8%.
From the Expanded Plan on Immunizations (PAI) they confirmed that at nationwide stage a complete of 3,982,577 folks have been vaccinated with the very first dose and 3,510,577 with the second dose. On the other hand, 1,582,665 citizens agreed to the initial booster (or third dose) and 275,665 to the fourth dose.
–
